US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist

1.090
-0.050-4.39%

Close Oct 1 16:00 ET

1.110
+0.020+1.83%

Post 18:32 ET

8.81MMarket Cap-132P/E (TTM)

Calidi Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-89.98%45K

Operating revenue

--0

-89.98%45K

--0

Cost of revenue

-85.11%14K

Gross profit

-91.27%31K

Operating expense

-1.01%5.59M

42.96%6.75M

12.73%26.11M

96.42%9.21M

-6.56%6.53M

5.65M

4.72M

113.70%23.16M

41.20%4.69M

6.99M

Selling and administrative expenses

7.29%3.61M

43.59%4.01M

0.52%15.98M

141.73%5.86M

-21.25%3.97M

--3.36M

--2.79M

158.02%15.9M

24.68%2.43M

--5.04M

-General and administrative expense

7.29%3.61M

43.59%4.01M

0.52%15.98M

141.73%5.86M

-21.25%3.97M

--3.36M

--2.79M

158.02%15.9M

24.68%2.43M

--5.04M

Research and development costs

-31.79%2.17M

4.61%2.74M

79.25%13.01M

74.90%3.96M

67.15%3.25M

--3.18M

--2.62M

55.26%7.26M

64.58%2.26M

--1.95M

Other operating expenses

79.64%-181K

----

---2.89M

---612K

---693K

---889K

---691K

----

Operating profit

1.01%-5.59M

-42.96%-6.75M

-12.88%-26.11M

-96.42%-9.21M

6.56%-6.53M

-5.65M

-4.72M

-120.64%-23.13M

-58.11%-4.69M

-6.99M

Net non-operating interest income expense

90.86%-273K

-16.59%-253K

-2,272.78%-3.75M

-126.53%-222K

-1,017.24%-324K

-2.99M

-217K

74.27%-158K

-58.06%-98K

-29K

Non-operating interest expense

-10.78%273K

16.59%253K

576.58%1.07M

126.53%222K

1,017.24%324K

--306K

--217K

-74.27%158K

58.06%98K

--29K

Total other finance cost

----

--2.68M

--0

----

--2.68M

----

Other net income (expense)

102.72%105K

85.77%-216K

130.80%656K

140.30%1.2M

191.33%4.84M

-3.86M

-1.52M

-1,324.14%-2.13M

-547.71%-2.97M

1.66M

Gain on sale of security

102.47%95K

86.85%-199K

155.44%1.18M

141.22%1.22M

220.94%5.32M

---3.85M

---1.51M

-1,032.02%-2.13M

-257.92%-2.96M

--1.66M

Special income (charges)

----

---471K

--0

---471K

----

--0

-Less:Other special charges

----

--471K

--0

--471K

----

Other non- operating income (expenses)

162.50%10K

-240.00%-17K

-920.00%-51K

-69.23%-22K

-300.00%-8K

---16K

---5K

-155.56%-5K

-316.67%-13K

--4K

Income before tax

53.92%-5.76M

-11.81%-7.22M

-14.89%-29.2M

-6.10%-8.23M

62.40%-2.01M

-12.5M

-6.46M

-132.70%-25.42M

-122.58%-7.76M

-5.35M

Income tax

100.00%8K

0.00%4K

45.45%16K

0.00%-3K

1,000.00%11K

0.00%11K

-200.00%-3K

Net income

53.87%-5.77M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-12.5M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

-5.36M

Net income continuous Operations

53.87%-5.77M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

---12.5M

---6.46M

-132.57%-25.43M

-122.30%-7.76M

---5.36M

Minority interest income

Net income attributable to the parent company

53.87%-5.77M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-12.5M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

-5.36M

Preferred stock dividends

Other preferred stock dividends

1.67M

Net income attributable to common stockholders

40.50%-7.44M

-11.81%-7.23M

-14.90%-29.22M

-6.10%-8.23M

62.20%-2.02M

-12.5M

-6.46M

-132.57%-25.43M

-122.30%-7.76M

-5.36M

Basic earnings per share

-302.12%-14

-11.13%-2

-144.30%-17.3

-7.25%-2.3166

6.13%-1.4

-3.4815

-1.7997

-132.57%-7.0814

-122.30%-2.1601

-1.4914

Diluted earnings per share

-302.12%-14

-11.13%-2

-144.30%-17.3

-7.25%-2.3166

6.13%-1.4

-3.4815

-1.7997

-132.57%-7.0814

-122.30%-2.1601

-1.4914

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	-89.98%45K	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	-89.98%45K	--0	--0
Cost of revenue			0	0	0			-85.11%14K	0	0
Gross profit			0	0	0			-91.27%31K	0	0
Operating expense	-1.01%5.59M	42.96%6.75M	12.73%26.11M	96.42%9.21M	-6.56%6.53M	5.65M	4.72M	113.70%23.16M	41.20%4.69M	6.99M
Selling and administrative expenses	7.29%3.61M	43.59%4.01M	0.52%15.98M	141.73%5.86M	-21.25%3.97M	--3.36M	--2.79M	158.02%15.9M	24.68%2.43M	--5.04M
-General and administrative expense	7.29%3.61M	43.59%4.01M	0.52%15.98M	141.73%5.86M	-21.25%3.97M	--3.36M	--2.79M	158.02%15.9M	24.68%2.43M	--5.04M
Research and development costs	-31.79%2.17M	4.61%2.74M	79.25%13.01M	74.90%3.96M	67.15%3.25M	--3.18M	--2.62M	55.26%7.26M	64.58%2.26M	--1.95M
Other operating expenses	79.64%-181K	----	---2.89M	---612K	---693K	---889K	---691K	----	----	----
Operating profit	1.01%-5.59M	-42.96%-6.75M	-12.88%-26.11M	-96.42%-9.21M	6.56%-6.53M	-5.65M	-4.72M	-120.64%-23.13M	-58.11%-4.69M	-6.99M
Net non-operating interest income expense	90.86%-273K	-16.59%-253K	-2,272.78%-3.75M	-126.53%-222K	-1,017.24%-324K	-2.99M	-217K	74.27%-158K	-58.06%-98K	-29K
Non-operating interest expense	-10.78%273K	16.59%253K	576.58%1.07M	126.53%222K	1,017.24%324K	--306K	--217K	-74.27%158K	58.06%98K	--29K
Total other finance cost	----	----	--2.68M	--0	----	--2.68M	----	----	----	----
Other net income (expense)	102.72%105K	85.77%-216K	130.80%656K	140.30%1.2M	191.33%4.84M	-3.86M	-1.52M	-1,324.14%-2.13M	-547.71%-2.97M	1.66M
Gain on sale of security	102.47%95K	86.85%-199K	155.44%1.18M	141.22%1.22M	220.94%5.32M	---3.85M	---1.51M	-1,032.02%-2.13M	-257.92%-2.96M	--1.66M
Special income (charges)	----	----	---471K	--0	---471K	----	----	--0	--0	--0
-Less:Other special charges	----	----	--471K	--0	--471K	----	----	----	----	----
Other non- operating income (expenses)	162.50%10K	-240.00%-17K	-920.00%-51K	-69.23%-22K	-300.00%-8K	---16K	---5K	-155.56%-5K	-316.67%-13K	--4K
Income before tax	53.92%-5.76M	-11.81%-7.22M	-14.89%-29.2M	-6.10%-8.23M	62.40%-2.01M	-12.5M	-6.46M	-132.70%-25.42M	-122.58%-7.76M	-5.35M
Income tax	100.00%8K	0.00%4K	45.45%16K	0.00%-3K	1,000.00%11K	4K	4K	0.00%11K	-200.00%-3K	1K
Net income	53.87%-5.77M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-12.5M	-6.46M	-132.57%-25.43M	-122.30%-7.76M	-5.36M
Net income continuous Operations	53.87%-5.77M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	---12.5M	---6.46M	-132.57%-25.43M	-122.30%-7.76M	---5.36M
Minority interest income
Net income attributable to the parent company	53.87%-5.77M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-12.5M	-6.46M	-132.57%-25.43M	-122.30%-7.76M	-5.36M
Preferred stock dividends
Other preferred stock dividends	1.67M					0
Net income attributable to common stockholders	40.50%-7.44M	-11.81%-7.23M	-14.90%-29.22M	-6.10%-8.23M	62.20%-2.02M	-12.5M	-6.46M	-132.57%-25.43M	-122.30%-7.76M	-5.36M
Basic earnings per share	-302.12%-14	-11.13%-2	-144.30%-17.3	-7.25%-2.3166	6.13%-1.4	-3.4815	-1.7997	-132.57%-7.0814	-122.30%-2.1601	-1.4914
Diluted earnings per share	-302.12%-14	-11.13%-2	-144.30%-17.3	-7.25%-2.3166	6.13%-1.4	-3.4815	-1.7997	-132.57%-7.0814	-122.30%-2.1601	-1.4914
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data